214 related articles for article (PubMed ID: 18437557)
1. Molecular mechanisms of the D327N SHBG protective role on breast cancer development after estrogen exposure.
Costantino L; Catalano MG; Frairia R; Carmazzi CM; Barbero M; Coluccia C; Donadio M; Genta F; Drogo M; Boccuzzi G; Fortunati N
Breast Cancer Res Treat; 2009 Apr; 114(3):449-56. PubMed ID: 18437557
[TBL] [Abstract][Full Text] [Related]
2. Sex Hormone-Binding Globulin (SHBG), estradiol and breast cancer.
Fortunati N; Catalano MG; Boccuzzi G; Frairia R
Mol Cell Endocrinol; 2010 Mar; 316(1):86-92. PubMed ID: 19770023
[TBL] [Abstract][Full Text] [Related]
3. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
[TBL] [Abstract][Full Text] [Related]
4. Sex hormone-binding globulin (SHBG) and estradiol cross-talk in breast cancer cells.
Fortunati N; Catalano MG
Horm Metab Res; 2006 Apr; 38(4):236-40. PubMed ID: 16700004
[TBL] [Abstract][Full Text] [Related]
5. Sex hormone-binding globulin antagonizes the anti-apoptotic effect of estradiol in breast cancer cells.
Catalano MG; Frairia R; Boccuzzi G; Fortunati N
Mol Cell Endocrinol; 2005 Jan; 230(1-2):31-7. PubMed ID: 15664449
[TBL] [Abstract][Full Text] [Related]
6. Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells.
Catalano MG; Costantino L; Frairia R; Boccuzzi G; Fortunati N
Horm Metab Res; 2007 Apr; 39(4):288-94. PubMed ID: 17447168
[TBL] [Abstract][Full Text] [Related]
7. Influence of SHBG gene pentanucleotide TAAAA repeat and D327N polymorphism on serum sex hormone-binding globulin concentration in hirsute women.
Cousin P; Calemard-Michel L; Lejeune H; Raverot G; Yessaad N; Emptoz-Bonneton A; Morel Y; Pugeat M
J Clin Endocrinol Metab; 2004 Feb; 89(2):917-24. PubMed ID: 14764814
[TBL] [Abstract][Full Text] [Related]
8. JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells.
Altiok N; Koyuturk M; Altiok S
Breast Cancer Res Treat; 2007 Nov; 105(3):247-54. PubMed ID: 17187235
[TBL] [Abstract][Full Text] [Related]
9. Fibulin-1 interacts with Sex Hormone Binding Globulin and is linked to less aggressive estrogen-dependent breast cancers.
Marano F; Zunino V; Frairia R; Arvat E; Castellano I; Bosco O; Catalano MG; Fortunati N
Life Sci; 2018 Aug; 207():372-380. PubMed ID: 29940241
[TBL] [Abstract][Full Text] [Related]
10. Direct inhibition of ERK1/2 phosphorylation as a possible mechanism for the antiproliferative action of 3,4-diOH-PCB3 in the MCF-7 cell line.
Ptak A; Gut P; Błachuta M; Rak A; Gregoraszczuk EŁ
Toxicol Lett; 2009 Oct; 190(2):187-92. PubMed ID: 19619627
[TBL] [Abstract][Full Text] [Related]
11. Sex hormone binding globulin inhibits strongly the uptake of estradiol by human breast carcinoma cells via a deprivative mechanism.
Zeginiadou T; Kortsaris AH; Koliais S; Antonoglou O
Cancer Biochem Biophys; 1998 Oct; 16(3):253-63. PubMed ID: 10072209
[TBL] [Abstract][Full Text] [Related]
12. Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy.
Würtz AM; Tjønneland A; Christensen J; Dragsted LO; Aarestrup J; Kyrø C; Overvad K; Olsen A
Cancer Causes Control; 2012 Oct; 23(10):1711-20. PubMed ID: 22926300
[TBL] [Abstract][Full Text] [Related]
13. Conjugated estrogens and breast cancer risk.
Campagnoli C; Ambroggio S; Biglia N; Sismondi P
Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():13-9. PubMed ID: 10862264
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells.
Fortunati N; Becchis M; Catalano MG; Comba A; Ferrera P; Raineri M; Berta L; Frairia R
J Steroid Biochem Mol Biol; 1999; 69(1-6):473-9. PubMed ID: 10419027
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability of estradiol as a marker for breast cancer risk assessment.
Jones LA; Ota DM; Jackson GA; Jackson PM; Kemp K; Anderson DE; McCamant SK; Bauman DH
Cancer Res; 1987 Oct; 47(19):5224-9. PubMed ID: 3621208
[TBL] [Abstract][Full Text] [Related]
16. Plasma sex hormone-binding globulin (SHBG) and obesity in breast cancer patients.
Murayama Y
Cancer Detect Prev; 1983; 6(4-5):425-33. PubMed ID: 6686084
[TBL] [Abstract][Full Text] [Related]
17. Intracellular sex hormone-binding globulin (SHBG) in normal and neoplastic breast tissue--an additional marker for hormone dependency?
Meyer S; Brumm C; Stegner HE; Sinnecker GH
Exp Clin Endocrinol; 1994; 102(4):334-40. PubMed ID: 7529185
[TBL] [Abstract][Full Text] [Related]
18. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
Koledova VV; Khalil RA
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
[TBL] [Abstract][Full Text] [Related]
19. [Sex hormone-binding globulin in breast cancer].
Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880
[TBL] [Abstract][Full Text] [Related]
20. The ability of hydroxylated estrogens (2-OH-E2 and 4-OH-E2) to increase of SHBG gene, protein expression and intracellular levels in MCF-7 cells line.
Gregoraszczuk EL; Ptak A; Wrobel A
Endocr Regul; 2011 Jul; 45(3):125-30. PubMed ID: 21793624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
